About Chelsea Therapeutics International (NASDAQ:CHTP)
Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson's Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension (IDH), fibromyalgia, adult attention deficit hyperactivity disorder (ADHD), chronic fatigue syndrome (CFS), freezing of gait in PD and Down syndrome. In addition, the Company is developing a portfolio of metabolically inert antifolates for the treatment of rheumatoid arthritis and is exploring potential applications in multiple other autoimmune disorders.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Chelsea Therapeutics International (NASDAQ:CHTP) Frequently Asked Questions
What is Chelsea Therapeutics International's stock symbol?
Chelsea Therapeutics International trades on the NASDAQ under the ticker symbol "CHTP."
Who are some of Chelsea Therapeutics International's key competitors?
Some companies that are related to Chelsea Therapeutics International include UnitedHealth Group (UNH), Roche (ROG), AbbVie (ABBV), Amgen (AMGN), Sanofi (SNY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Sanofi (SAN), Bayer (BAYN), Thermo Fisher Scientific (TMO), Danaher (DHR), GlaxoSmithKline (GSK), CSL (CSL), Aetna (AET), Cigna (CI), Becton Dickinson and (BDX) and Shire (SHPG).
How do I buy Chelsea Therapeutics International stock?
Shares of Chelsea Therapeutics International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Chelsea Therapeutics International?
Chelsea Therapeutics International's mailing address is 3530 Toringdon Way Ste 200, CHARLOTTE, NC 28277-3436, United States. The healthcare company can be reached via phone at +1-704-3411516.
MarketBeat Community Rating for Chelsea Therapeutics International (CHTP)MarketBeat's community ratings are surveys of what our community members think about Chelsea Therapeutics International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Chelsea Therapeutics International (NASDAQ:CHTP) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Chelsea Therapeutics International (NASDAQ:CHTP) Earnings History and Estimates Chart
Chelsea Therapeutics International (NASDAQ CHTP) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Chelsea Therapeutics International (NASDAQ:CHTP) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Chelsea Therapeutics International (NASDAQ:CHTP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Chelsea Therapeutics International (NASDAQ CHTP)
No insider trades for this company have been tracked by MarketBeat.com
Chelsea Therapeutics International (NASDAQ CHTP) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Chelsea Therapeutics International (NASDAQ:CHTP) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Chelsea Therapeutics International (NASDAQ:CHTP) Income Statement, Balance Sheet and Cash Flow Statement
Chelsea Therapeutics International (NASDAQ CHTP) Stock Chart for Thursday, December, 14, 2017